🇺🇸 FDA
Patent

US 9259488

Anti-C3d antibody conjugates and methods of detecting complement activation

granted A61KA61K49/0058A61K49/1875

Quick answer

US patent 9259488 (Anti-C3d antibody conjugates and methods of detecting complement activation) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K49/0058, A61K49/1875, A61P, A61P37/00